Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2893483 | 1.00 | KMT2A (0.51) | KMT2APTGS1PTGS2TSHRSMN1; SMN2 | |
| SCHEMBL13305895 | 0.91 | KMT2A (0.46) | KMT2APTGS1PTGS2SMN1; SMN2NPSR1 | |
| SCHEMBL13305881 | 0.91 | KMT2A (0.46) | KMT2APTGS1PTGS2TSHRSMN1; SMN2 | |
| SCHEMBL16841424 | 0.85 | KMT2A (0.53) | KMT2APTGS1PTGS2TSHRSMN1; SMN2 | |
| SCHEMBL12892652 | 0.84 | KDM4E (0.50) | KMT2ATSHRSMN1; SMN2ALDH1A1MEN1 | |
| SCHEMBL16093068 | 0.83 | KMT2A (0.50) | KMT2APTGS1PTGS2TSHRSMN1; SMN2 | |
| SCHEMBL16128973 | 0.81 | TDP1 (0.44) | PTGS1PTGS2TSHRSMN1; SMN2LMNA | |
| SCHEMBL12423871 | 0.80 | KMT2A (0.47) | KMT2APTGS1PTGS2TSHRSMN1; SMN2 | |
| Propane SCHEMBL3346178 | 0.80 | KMT2A (0.47) | KMT2APTGS1PTGS2TSHRSMN1; SMN2 | |
| SCHEMBL16866714 | 0.80 | CHRM1 (0.40) | SMN1; SMN2NPSR1LMNAALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4682535-A1 | EXTRACELLULAR VESICLE DISSOCIATING AGENT AND EXTRACELLULAR VESICLE PURIFICATION METHOD | NOF Corporation (JP) | 2026-01-21 | — | — | EP | disclosed |
| EP-4644354-A1 | POLYMER MECHANORADICAL INITIATOR AND REACTION METHOD USING POLYMER MECHANORADICAL INITIATOR | National University Corporation Hokkaido University (JP) | 2025-11-05 | — | — | EP | disclosed |
| EP-3733722-B1 | ZWITTERIONIC POLYMER, METHOD FOR PRODUCING SAME AND PROTEIN STABILIZER CONTAINING ZWITTERIONIC POLYMER | UNIV YAMAGATA NAT UNIV CORP (JP) | 2025-10-08 | — | — | EP | disclosed |
| WO-2025079620-A1 | MICROFLUIDIC SYSTEM, PROCESSING METHOD USING MICROFLUIDIC SYSTEM, AND METHOD FOR PRODUCING POLYMER | 株式会社ダイセル | 2025-04-17 | — | — | WO | disclosed |
| WO-2025079618-A1 | MICROFLUIDIC SYSTEM, REACTION METHOD FOR EMPLOYING MICROFLUIDIC SYSTEM, AND METHOD FOR PRODUCING POLYMER | 株式会社ダイセル | 2025-04-17 | — | — | WO | disclosed |
| WO-2025079622-A1 | MICROFLUIDIC SYSTEM, REACTION METHOD USING MICROFLUIDIC SYSTEM, AND METHOD FOR PRODUCING POLYMER | 株式会社ダイセル | 2025-04-17 | — | — | WO | disclosed |
| WO-2025079623-A1 | METHOD FOR PRODUCING POLYMER | 株式会社ダイセル | 2025-04-17 | — | — | WO | disclosed |
| WO-2025079624-A1 | METHOD FOR PRODUCING POLYMER | 株式会社ダイセル | 2025-04-17 | — | — | WO | disclosed |
| WO-2024190766-A1 | EXTRACELLULAR VESICLE DISSOCIATING AGENT AND EXTRACELLULAR VESICLE PURIFICATION METHOD | 日油株式会社 | 2024-09-19 | — | — | WO | disclosed |
| US-20240200025-A1 | CELL DISSOCIATING AGENT AND CELL SEPARATION METHOD | NOF CORPORATION (JP) | 2024-06-20 | — | — | US | disclosed |
| EP-2412756-A1 | CURABLE COMPOSITION | CEMEDINE CO., LTD. (JP) | 2012-02-01 | — | — | EP | disclosed |
| US-20120004371-A1 | CURABLE COMPOSITION | CEMEDINE CO., LTD. (JP) | 2012-01-05 | — | — | US | disclosed |
| US-20100285276-A1 | Methods for the preparation of coil-comb block copolymers and their nanostructures | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2010-11-11 | — | — | US | disclosed |
| US-20100285276-A1 | Methods for the preparation of coil-comb block copolymers and their nanostructures | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2010-11-11 | — | — | US | disclosed |
| US-20100285276-A1 | Methods for the preparation of coil-comb block copolymers and their nanostructures | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2010-11-11 | — | — | US | disclosed |
| US-20100160574-A1 | Polymerisation Using Chain Transfer Agents | THE UNIVERSITY OF LEEDS (GB) | 2010-06-24 | — | — | US | disclosed |
| US-20090215965-A1 | POLYMERISATION USING CHAIN TRANSFER AGENTS | THE UNIVERSITY OF LEEDS (GB) | 2009-08-27 | — | — | US | disclosed |
| US-20070299221-A1 | Polymerisation Using Chain Transfer Agents | UNIVERSITY OF LEEDS, THE (GB) | 2007-12-27 | — | — | US | disclosed |
| EP-1697424-A1 | POLYMERISATION USING CHAIN TRANSFER AGENTS | THE UNIVERSITY OF LEEDS (GB) | 2006-09-06 | — | — | EP | disclosed |
| WO-2005061555-A1 | POLYMERISATION USING CHAIN TRANSFER AGENTS | THE UNIVERSITY OF LEEDS (GB) | 2005-07-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160574-A1 | Polymerisation Using Chain Transfer Agents | TRRAP, TRMT1, IPO11 | KMT2A 1898/4885PTGS1 1017/4885PTGS2 1223/4885 |
| US-20090215965-A1 | POLYMERISATION USING CHAIN TRANSFER AGENTS | TRRAP, TRMT1, IPO11 | KMT2A 1898/4885PTGS1 1017/4885PTGS2 1223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.